Abstract
Antisense and Nucleic Acid Drug DevelopmentVol. 7, No. 3 Protein Kinase C as a Target for Cancer TherapyROBERT I. GLAZERROBERT I. GLAZERSearch for more papers by this authorPublished Online:30 Jan 2009https://doi.org/10.1089/oli.1.1997.7.235AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byHow and Why to Apply the Latest Technology*Induction of p53-Dependent, Insulin-Like Growth Factor-Binding Protein-3-Mediated Apoptosis in Glioblastoma Multiforme Cells by a Protein Kinase Cα Antisense Oligonucleotide1 February 1999 | Molecular Pharmacology, Vol. 55, No. 2Antisense Oligonucleotides Specific for the HER2/neu Oncogene Inhibit the Growth of Human Breast Carcinoma Cells That Overexpress HER2/neuJournal of Surgical Research, Vol. 77, No. 1Post-translational modification of proteins and the discovery of new medicineCurrent Opinion in Biotechnology, Vol. 8, No. 6 Volume 7Issue 3Jun 1997 To cite this article:ROBERT I. GLAZER.Protein Kinase C as a Target for Cancer Therapy.Antisense and Nucleic Acid Drug Development.Jun 1997.235-238.http://doi.org/10.1089/oli.1.1997.7.235Published in Volume: 7 Issue 3: January 30, 2009PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
